InvestorsHub Logo
icon url

igotthemojo

09/26/19 11:39 PM

#172681 RE: GTman1 #172647

wow...you put kblb in the same category as biotech companies that are strictly in the medical field?...

I just looked at the first 2 real quick...

intellia ip'd ONTO Nasdaq in 2016 at $22.00 per share, rasing $108 mil..

editas ipo'd in 2016 ONTO Nasdaq at $16.00 per share, rasing $94 mil..

now...explain to me how they compare in any way to a 20 cent otc company that has been a public company for ten years and now wants to do a 1/40 r/s to get themselves onto Nasdaq?...

theres just no comparison...you may as well have used tesla
icon url

sonicty28

09/27/19 10:49 AM

#172707 RE: GTman1 #172647

And these companies get shorted by far more than anything else on the exchange. I was in one, ADXS that was so heavily shorted it destroyed the stock to pennies and caused a massive RS that failed miserably.